Monday, September 23, 2024 11:01:16 AM
What I would give for one of my holdings to have gone from trips,
to 2.5 cents in a weeks time; which this one did a while back ago.
Those who made big bucks, can now be happy to look at it again and start all over.
It's all about timing. IMO, market always over react to dilution.
The share structure here and float is very decent still. I'm sure it's a great accumulation area again.
With a high of 6 cents for the year, I'm sure they will run it again at some point.
Yes, IMO, the only risk at this level would be a RS, but share structure and their history doesn't make that likely
to 2.5 cents in a weeks time; which this one did a while back ago.
Those who made big bucks, can now be happy to look at it again and start all over.
It's all about timing. IMO, market always over react to dilution.
The share structure here and float is very decent still. I'm sure it's a great accumulation area again.
With a high of 6 cents for the year, I'm sure they will run it again at some point.
Yes, IMO, the only risk at this level would be a RS, but share structure and their history doesn't make that likely
Recent AIMN News
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
